RXL

Ultra Health Care

Investment Objective

ProShares Ultra Health Care seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select SectorSM Index.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
RXL Market Price -12.83% -21.08% -13.12% -2.71% -2.71% -7.23% 7.11% 11.42% 14.52% 01/30/2007
RXL NAV -12.59% -21.05% -12.97% -2.66% -2.66% -7.18% 7.11% 11.47% 14.52% 01/30/2007

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    RXL
  • Intraday Ticker
    RXL.IV
  • CUSIP
    74347R735
  • Inception Date
    1/30/07
  • Gross Expense Ratio
    1.05%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 1/17/2025
  • NAV
    $45.59
  • NAV Change
    $-0.65 down caret
  • Market Price
    $45.62
  • Market Price Change
    $-0.63 down caret
  • Trading Volume (M)
    1,340
  • 30-Day Median Bid Ask Spread
    0.07%
  • View Premium / Discount
Snapshot
  • Ticker
    RXL
  • Intraday Ticker
    RXL.IV
  • CUSIP
    74347R735
  • Inception Date
    1/30/07
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.05%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 1/17/2025
  • NAV
    $45.59
  • NAV Change
    $-0.65 down caret
  • Market Price
    $45.62
  • Market Price Change
    $-0.63 down caret
  • Trading Volume (M)
    1,340
  • 30-Day Median Bid Ask Spread
    0.07%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 9/30/2024

Holdings

as of 1/17/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
8.40% LLY ELI LILLY & CO -- $6,203,454.56 8,548 2516152
6.89% UNH UNITEDHEALTH GROUP INC -- $5,089,443.84 9,984 2917766
5.20% JNJ JOHNSON & JOHNSON -- $3,841,599.84 26,128 2475833
4.45% ABBV ABBVIE INC -- $3,288,976.76 19,171 B92SR70
3.64% MRK MERCK & CO. INC. -- $2,687,218.56 27,443 2778844
3.14% TMO THERMO FISHER SCIENTIFIC INC -- $2,321,987.85 4,149 2886907
3.10% ISRG INTUITIVE SURGICAL INC -- $2,289,960.96 3,864 2871301
2.89% ABT ABBOTT LABORATORIES -- $2,135,353.16 18,817 2002305
2.25% DHR DANAHER CORP -- $1,662,084.28 6,973 2250870
2.19% PFE PFIZER INC -- $1,616,897.70 61,479 2684703
2.15% AMGN AMGEN INC -- $1,586,945.52 5,832 2023607
2.14% BSX BOSTON SCIENTIFIC CORP -- $1,577,474.74 15,989 2113434
1.93% SYK STRYKER CORP -- $1,427,089.24 3,722 2853688
1.68% GILD GILEAD SCIENCES INC -- $1,241,676.80 13,520 2369174
1.68% BMY BRISTOL-MYERS SQUIBB CO -- $1,238,548.87 22,003 2126335
1.66% MDT MEDTRONIC PLC -- $1,225,457.04 13,913 BTN1Y11
1.60% VRTX VERTEX PHARMACEUTICALS INC -- $1,178,646.00 2,793 2931034
1.31% ELV ELEVANCE HEALTH INC -- $969,389.64 2,516 BSPHGL4
1.16% CI THE CIGNA GROUP -- $857,081.82 3,018 BHJ0775
1.10% MCK MCKESSON CORP -- $815,968.89 1,377 2378534
1.10% ZTS ZOETIS INC -- $811,865.66 4,894 B95WG16
1.05% REGN REGENERON PHARMACEUTICALS -- $778,364.36 1,142 2730190
1.01% BDX BECTON DICKINSON AND CO -- $744,423.68 3,136 2087807
0.97% CVS CVS HEALTH CORP -- $718,263.00 13,650 2577609
0.83% HCA HCA HEALTHCARE INC -- $614,380.55 1,979 B4MGBG6
0.62% COR CENCORA INC -- $460,621.15 1,903 2795393
0.62% A AGILENT TECHNOLOGIES INC -- $459,321.12 3,117 2520153
0.60% EW EDWARDS LIFESCIENCES CORP -- $446,452.44 6,398 2567116
0.57% GEHC GE HEALTHCARE TECHNOLOGY -- $420,056.18 4,957 BL6JPG8
0.52% RMD RESMED INC -- $381,729.76 1,592 2732903
0.50% IDXX IDEXX LABORATORIES INC -- $372,722.14 889 2459202
0.50% IQV IQVIA HOLDINGS INC -- $369,260.56 1,871 BDR73G1
0.50% HUM HUMANA INC -- $369,114.78 1,306 2445063
0.48% DXCM DEXCOM INC -- $357,602.44 4,238 B0796X4
0.46% CNC CENTENE CORP -- $340,943.25 5,477 2807061
0.45% CAH CARDINAL HEALTH INC -- $331,585.02 2,626 2175672
0.40% MTD METTLER-TOLEDO INTERNATIONAL -- $296,653.47 229 2126249
0.36% WST WEST PHARMACEUTICAL SERVICES -- $264,363.24 786 2950482
0.35% WAT WATERS CORP -- $260,176.00 644 2937689
0.32% ZBH ZIMMER BIOMET HOLDINGS INC -- $236,649.60 2,160 2783815
0.30% STE STERIS PLC -- $224,503.02 1,071 BFY8C75
0.30% BIIB BIOGEN INC -- $222,209.55 1,581 2455965
0.29% LH LABCORP HOLDINGS INC -- $216,612.48 908 BSBK800
0.28% PODD INSULET CORP -- $209,891.41 761 B1XGNW4
0.27% COO COOPER COS INC/THE -- $201,463.20 2,160 BQPDXR3
0.25% DGX QUEST DIAGNOSTICS INC -- $183,103.20 1,211 2702791
0.24% MOH MOLINA HEALTHCARE INC -- $177,736.41 621 2212706
0.24% HOLX HOLOGIC INC -- $175,719.60 2,520 2433530
0.23% BAX BAXTER INTERNATIONAL INC -- $171,536.26 5,537 2085102
0.23% ALGN ALIGN TECHNOLOGY INC -- $170,639.03 761 2679204
0.21% RVTY REVVITY INC -- $156,274.80 1,320 2305844
0.20% VTRS VIATRIS INC -- $146,323.70 12,949 BMWS3X9
0.18% TECH BIO-TECHNE CORP -- $130,730.92 1,724 BSHZ3Q0
0.17% MRNA MODERNA INC -- $125,136.44 3,674 BGSXTS3
0.17% INCY INCYTE CORP -- $124,798.55 1,735 2471950
0.16% UHS UNIVERSAL HEALTH SERVICES-B -- $117,717.60 637 2923785
0.15% SOLV SOLVENTUM CORP -- $110,191.49 1,499 BMTQB43
0.13% HSIC HENRY SCHEIN INC -- $99,066.66 1,353 2416962
0.12% TFX TELEFLEX INC -- $91,360.08 504 2881407
0.12% CRL CHARLES RIVER LABORATORIES -- $90,742.50 555 2604336
0.11% DVA DAVITA INC -- $81,291.36 489 2898087
47.85% -- HEALTH CARE SELECT SECTOR INDEX SWAP UBS AG 35,337,067 -- 24,939 --
47.44% -- HEALTH CARE SELECT SECTOR INDEX SWAP BANK OF AMERICA NA 35,035,258 -- 24,726 --
10.34% -- HEALTH CARE SELECT SECTOR INDEX SWAP BNP PARIBAS 7,635,040 -- 5,388 --
9.71% -- HEALTH CARE SELECT SECTOR INDEX SWAP GOLDMAN SACHS INTERNATIONAL 7,168,299 -- 5,059 --
8.89% -- HEALTH CARE SELECT SECTOR INDEX SWAP SOCIETE GENERALE 6,566,100 -- 4,634 --
1.47% -- HEALTH CARE SELECT SECTOR INDEX SWAP CITIBANK NA 1,085,376 -- 766 --
-- -- TREASURY BILL -- $4,982,406.95 5,000,000 BPG5RS0
-- -- TREASURY BILL -- $1,491,373.97 1,500,000 BNDXZ56
-- -- NET OTHER ASSETS (LIABILITIES) -- $11,861,986.73 11,861,987 --

Index

as of 9/30/2024

  • Total Number of Companies62
  • Price/Earnings Ratio22.241
  • Price/Book Ratio5.143
  • Dividend Yield ( % )1.56
  • Avg. Index Market Capitalization$94.87 billion
About the Index

The S&P Health Care Select Sector Index is designed to measure the performance of health care companies included in the S&P 500 Index.

The Index includes health care companies in the following industries according to the Global Industry Classification Standard (GICS): health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.